PRIMERICA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 228.2 USD | +1.74% |
|
+2.00% | +10.93% |
| May. 08 | Transcript : Primerica, Inc. - Shareholder/Analyst Call | |
| May. 07 | Transcript : Primerica, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Strengths
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Sales forecast by analysts have been recently revised upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +10.93% | 7.85B | B | ||
| +12.16% | 110B | B | ||
| +28.46% | 107B | B- | ||
| -4.04% | 93.7B | B+ | ||
| +17.05% | 73.68B | D+ | ||
| +21.74% | 35.28B | B | ||
| +15.12% | 30.15B | A | ||
| +15.32% | 29.95B | B | ||
| +0.51% | 17.24B | C+ | ||
| -11.95% | 14.72B | B |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- PRI Stock
- Ratings Primerica, Inc.
